Peter Schiff: There Is No Vaccine For What Ails The Economy
Fauci Admitted The Truth About COVID-19 Tests In July And Has Misled The Public Since
News briefing: Locus Biosciences bags up to $12.1M for CRISPR antibacterial; Old Vertex drug heads to PhIII for dementia
Pfizer COVID vaccine: promising results – here's what needs to happen next
US COVID-19 Hospitalizations Match April Highs As US Tops 100k Cases For 6th Day: Live Updates
Shimmer Research receives CE certification for its Verisense Inertial Measurement Unit (IMU) sensor for clinical trials
Global Rally Fizzles, Nasdaq Tumbles As Pfizer Vaccine Skepticism Emerges
Lilly to ship COVID-19 drug straight away after FDA green light
Eli Lilly’s Covid-19 Antibody Treatment Gets FDA Emergency Use Nod
It’s just a jump to the left
Novavax on track to begin U.S. trial of Covid-19 vaccine in November
U.S. allows emergency use of first Covid-19 antibody drug
Multiple States And FDA Warn Of "Careless" Rapid Antigen Testing In Asymptomatic COVID Cases
Pfizer CEO Albert Bourla On Covid-19 Vaccine Efficacy
Dr. Fauci Praises Biden Plan, Says He Would Like To Stay On, As US Tops 10 Million COVID-19 Cases: Live Updates
US COVID-19 Cases Top 10MN, Nebraska Issues Mandatory Mask Order; Italy Tightens Restrictions: Live Updates
Moderna: Ahead of COVID-19 Vaccine Data, This Analyst Stays Bullish
Biogen plunges 30% after FDA panel votes against Alzheimer’s drug
US Dollar Drops As Pfizer, BioNTech Announce 90% Effective COVID-19 Vaccine
Pfizer, BioNTech Announce COVID-19 Vaccine is 90% Effective; Shares Pop in Pre-Market Trading
Pfizer/BioNTech say vaccine works in 90% of COVID-19 patients
Ocular Therapeutix Rises 7% On Stellar Results Backed By Dextenza
Digital therapies for opioid use disorder need more data, says ICER
Biden Taps BARDA Whistleblower Rick Bright for Covid-19 Advisory Board
Combative U.S. FDA panel votes against Biogen Alzheimer’s drug
AstraZeneca’s Heart Drug Gets FDA Nod For Stroke Reduction Use
Expert panel review on Alzheimer’s drug aducanumab becomes a one-day trial by fire as critics turn their guns on Biogen — and the FDA
MIT Develops AI Tool To Detect COVID By Listening To Coughs
Expert panel review on the Alzheimer’s drug aducanumab turns into a one-day trial by fire as critics turn their guns on Biogen — and the FDA
U.S. FDA panel votes successful study on Biogen Alzheimer’s drug cannot stand alone